Usana Health Sciences/$USNA
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Usana Health Sciences
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.
Ticker
$USNA
Sector
Primary listing
NYSE
Employees
1,700
Headquarters
Website
USNA Metrics
BasicAdvanced
$374M
22.79
$0.90
0.64
-
Price and volume
Market cap
$374M
Beta
0.64
52-week high
$38.32
52-week low
$18.48
Average daily volume
132K
Financial strength
Current ratio
2.225
Quick ratio
1.225
Interest coverage (TTM)
49.32%
Profitability
EBITDA (TTM)
69.051
Gross margin (TTM)
79.18%
Net profit margin (TTM)
1.86%
Operating margin (TTM)
4.58%
Effective tax rate (TTM)
63.26%
Revenue per employee (TTM)
$540,000
Management effectiveness
Return on assets (TTM)
3.74%
Return on equity (TTM)
3.15%
Valuation
Price to earnings (TTM)
22.785
Price to revenue (TTM)
0.42
Price to book
0.71
Price to tangible book (TTM)
1.53
Price to free cash flow (TTM)
20.525
Free cash flow yield (TTM)
4.87%
Free cash flow per share (TTM)
0.998
Growth
Revenue change (TTM)
5.88%
Earnings per share change (TTM)
-68.25%
3-year revenue growth (CAGR)
-4.20%
10-year revenue growth (CAGR)
-0.01%
3-year earnings per share growth (CAGR)
-39.12%
10-year earnings per share growth (CAGR)
-12.73%
What the Analysts think about USNA
Analyst ratings (Buy, Hold, Sell) for Usana Health Sciences stock.
USNA Financial Performance
Revenues and expenses
USNA Earnings Performance
Company profitability
USNA News
AllArticlesVideos
USANA Health Sciences Provides Preliminary Fiscal Year 2025 Net Sales and Issues Initial Fiscal Year 2026 Net Sales Outlook
Business Wire·4 days ago
USANA Health Sciences Reports Third Quarter 2025 Results and Updates Full-Year Outlook
Business Wire·3 months ago
USANA Updates the Timing of the Release of Third Quarter 2025 Earnings Release and Conference Call
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Usana Health Sciences stock?
Usana Health Sciences (USNA) has a market cap of $374M as of January 16, 2026.
What is the P/E ratio for Usana Health Sciences stock?
The price to earnings (P/E) ratio for Usana Health Sciences (USNA) stock is 22.79 as of January 16, 2026.
Does Usana Health Sciences stock pay dividends?
No, Usana Health Sciences (USNA) stock does not pay dividends to its shareholders as of January 16, 2026.
When is the next Usana Health Sciences dividend payment date?
Usana Health Sciences (USNA) stock does not pay dividends to its shareholders.
What is the beta indicator for Usana Health Sciences?
Usana Health Sciences (USNA) has a beta rating of 0.64. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.